Godavari Drugs Ltd
Know More96.35↑-1.65 (-1.68%)
12:00 AM,22nd Sep 2023BSE : 530317
NSE :
Sector : Health care
ISIN Code : INE362C01012
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Sep 22 2023 | 12:00 AM IST
| Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Godavari Drugs Ltd
Godavari Drugs is engaged in manufacturing drugs. Sulphamethoxazole (SMX) the main product of the company is a widely used anti-bacterial drug enjoying good export demand.The company has expanded its SMX capacity from 540 tpa to 720 tpa integrating backward into the manufacture of drug intermediates sulphamethoxide (cap.: 450 tpa) and diethyl oxalate DEO (cap.: 750 tpa) and diversifying into the manufacture of trimetroprim TMP (cap.: 144 tpa).The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections. The backward integration into SMO and DEO will enhance value-addition. In fact Siris and Chemox Chemicals both having good capacities of SMX have recently gone in for the production of SMO. In 2000 the company introduced 'Pyrazyamide' in the market. Since the product is being well accepted in the market the company is planning to increase the capacity of 'Pyrazyamide' of 180 TPA and have also finalised on other products Cislactumwhich is a intermediate used to produce Diltiazem an anti anginal drug.
News
View MoreAnnouncement
View MoreGodavari Drugs Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 72 |
| EPS - TTM (₹) [S] | 4.62 |
| P/E Ratio (X) [S] | 2.17 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | 44.38 |
| P/B Ratio (₹) [S] | 2.17 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|
Research Reports
| Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
|---|---|---|---|---|
| Data Not Found |
Stock Strength
| Today's Low/High | 95.00 100.95 |
| Week Low/High | 88.00 114.00 |
| Month Low/High | 88.00 114.00 |
| Year Low/High | 57.00 114.00 |
| All time Low/High | 1.00 114.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -5.03% | % | -2.70 | -2.57% |
| 1 Month | -1.83% | % | 1.21 | 1.43% |
| 3 Month | -2.89% | % | 4.38 | 4.81% |
| 6 Month | 21.50% | % | 13.66 | 15.00% |
| 1 Year | 42.42% | % | 11.65 | 11.60% |
| 3 Year | 171.41% | % | 74.93 | 76.39% |
Financials
- Financial Overview
- Income Statement
- Balance Sheet
- Profit & Loss
- Cash Flow Statement
- Ratios
- Revenue (Rs Cr)
- Net Profit (Rs Cr)
- Operating Profit (Rs Cr)
- Earnings Per Share(Rs)
- Book Value(Rs per share)
- Net Worth(Rs Cr)
- Divident(%)
- Dividend Payout(Rs Cr)
Bulk/ Block
| Date | Client Name | Exchange | Transaction | Quantity | Price |
|---|---|---|---|---|---|
| 15-06-2023 | PRASHANT SHRIMAL | BSE | SELL | 41833 | 93.52 |
| 06-06-2023 | MOHIT JAJU | BSE | BUY | 70000 | 87.99 |
| 06-06-2023 | PRASHANT SHRIMAL | BSE | SELL | 155167 | 88.00 |
| 06-06-2023 | SUSHMA KAKANI | BSE | BUY | 70000 | 88.00 |
| 19-12-2022 | ARHAM SHARE PRIVATE LIMITED | BSE | SELL | 40564 | 74.93 |
| 19-12-2022 | ARHAM SHARE PRIVATE LIMITED | BSE | BUY | 40564 | 75.80 |
| 19-12-2022 | NEERAJ JAIN | BSE | SELL | 37900 | 75.80 |
| 19-12-2022 | YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . | BSE | SELL | 45000 | 75.76 |
| 19-12-2022 | YUGA STOCKS AND COMMODITIES PRIVATE LIMITED . | BSE | BUY | 45000 | 75.78 |
| 11-03-2022 | MOHIT JAJU | BSE | BUY | 37900 | 59.40 |
Load More | |||||
Peer Group Comparison
- Ratio Performance
- Stock Performance
| Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
|---|
Shareholding Pattern
- Total shareholdings
| Category | Share(%) |
|---|---|
| Promoter | 53.16 |
| Financial Institutions Banks | 0.50 |
| Foreign Institutional Investors | 0.00 |
| Insurance Companies | 0.00 |
| Mutual Funds Uti | 0.00 |
| Other Institutional Investors | 0.00 |
| Indian Public | 38.75 |
| Others Non Institutional Investors | 7.59 |
| Custodians | 0.00 |
Corporate Action
| Announcement Date | Purpose | From | To | Remarks |
|---|---|---|---|---|
| Data Not Found |
Price History
Search for Price History
| Date | Open | High | Low | Close | Shares | Trades |
|---|---|---|---|---|---|---|
| Data Not Found |
Load more
Company Info
Company Information
Managing Director : Mukund Kakani
Non-Exec. & Independent Dir. : S A Hussain
Whole Time Director & CFO : Mohit Jaju
Non-Exec. & Independent Dir. : Ramesh Babu Telugu
Non-Exec. & Independent Dir. : Vimala B Madon
Chairman (Non-Executive) : Ghanshyam Jaju
Non Executive Director : Mahindra Uday Bhalerao
Company Sec. & Compli. Officer : Venkatesh Achanta
Registered Office: Mayfair 1-8-303-34, Sardar Patel Road,Secunderabad,Andhra Pradesh-500003 Ph: 91-40-27849700/27844557
Email:info@godavaridrugs.com
